MSDS | : | 3-Aminobenzotrifluoride, 99+ % | CAS | : | 98-16-8 | SYNONYMS | : | 3-(Trifluoromethyl)aniline; alpha,alpha,alpha-Trifluoro-m-toluidine; 3-(Trifluoromethyl)aniline; 3-(Trifluoromethyl)benzenamine; 3-Aminobenzotrifluoride; 3-Trifluoromethylaniline; Aniline, 3-trifluoromethyl-; Benzenamine, 3-(trifluoromethyl)-; Benzeneamine, 3-(trifluoromethyl); m-(Trifluoromethyl)aniline; m-Abtf; m-Aminobenzal fluoride; m-Aminobenzotrifluoride; m-Toluidine, alpha,alpha,alpha-trifluoro-; m-Toluidine, alpha,alpha,alpha-trifluoro-; Toluene, 3-amino-alpha,alpha,alpha-trifluoro- |
| |
|
|
**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 98-16-8 |3-Aminobenzotrifluoride | 99+ | 202-643-4 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 21/22 36/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful in contact with skin and if swallowed. Irritating to eyes
and skin.Light sensitive.Air sensitive.
Potential Health Effects
Eye:
Causes moderate eye irritation. May cause chemical conjunctivitis
and corneal damage.
Skin:
May cause dermatitis. May cause severe skin irritation and burns.
May cause cyanosis of the extremities.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May cause headache, nausea, fatigue, and dizziness. May
form methemoglobin which in sufficient concentration causes cyanosis
(bluish discoloration of skin due to deficient oxygenation of the
blood).
Inhalation:
May cause severe respiratory tract irritation. Aspiration may lead
to pulmonary edema. Methemoglobinemia is characterized by dizziness,
drowsiness, headache, shortness of breath, cyanosis (bluish
discoloration of skin due to deficient oxygenation of the blood),
rapid heart rate and chocolate-brown blood. May cause burning
sensation, coughing, wheezing, laryngitis, shortness of breath,
headache, nausea, and vomiting. Inhalation at high concentrations
may cause CNS depression and asphixiation.
Chronic:
Absorption into the body leads to the formation of methemoglobin
which in sufficient concentrations causes cyanosis (bluish
discoloration of skin due to deficient oxygenation of the blood).
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid immediately. Do NOT induce vomiting. If conscious and alert,
rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Use water spray to keep fire-exposed containers
cool. Combustible liquid. Vapors may be heavier than air. They can
spread along the ground and collect in low or confined areas.
Containers may explode when heated.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or
alcohol-resistant foam. Use water spray to cool fire-exposed
containers.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Remove all sources of ignition.
Use a spark-proof tool. Place under an inert atmosphere.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use only in a well-ventilated area.
Use with adequate ventilation. Empty containers retain product
residue, (liquid and/or vapor), and can be dangerous. Keep container
tightly closed. Keep away from heat, sparks and flame. Store
protected from light. Handle under an inert atmosphere. Store
protected from air. Do not pressurize, cut, weld, braze, solder,
drill, grind, or expose empty containers to heat, sparks or open
flames.
Storage:
Keep away from heat, sparks, and flame. Keep away from sources of
ignition. Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Do not expose
to air. Store protected from light. Store under an inert atmosphere.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local explosion-proof ventilation to keep airborne levels to
acceptable levels.
Exposure Limits
CAS# 98-16-8:
United States OSHA: 2.5 mg/m3 TWA (as F) (listed under Fluorides
Russia: 0.5 mg/m3 TWA
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: clear very light yellow
Odor: None reported.
pH: Not available.
Vapor Pressure: 0.3 mm Hg @ 20 deg C
Viscosity: Not available.
Boiling Point: 187 deg C @ 760.00mmHg
Freezing/Melting Point: 5.00 - 6.00 deg C
Autoignition Temperature: > 600 deg C (> 1,112.00 deg F)
Flash Point: 85 deg C ( 185.00 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Slightly soluble.
Specific Gravity/Density: 1.2900g/cm3
Molecular Formula: H2NC6H4CF3
Molecular Weight: 161.13
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures. Air sensitive. Light
sensitive.
Conditions to Avoid:
Incompatible materials, light, ignition sources, exposure to air,
excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents, air.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide, hydrogen fluoride
gas, fluoride fumes.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 98-16-8: XU9180000
LD50/LC50:
CAS# 98-16-8: Draize test, rabbit, eye: 100 uL Moderate; Inhalation,
mouse: LC50 = 690 mg/m3/2H; Inhalation, rat: LC50 = 440 mg/m3/4H;
Oral, mouse: LD50 = 220 mg/kg; Oral, rabbit: LD50 = 615 mg/kg; Oral,
rat: LD50 = 480 mg/kg; Skin, rabbit: LD50 = 1330 mg/kg.
Skin, rabbit: LD50 = 1330
Carcinogenicity:
3-Aminobenzotrifluoride -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: 3-TRIFLUOROMETHYLANILINE
Hazard Class: 6.1
UN Number: 2948
Packing Group: II
IMO
Shipping Name: 3-TRIFLUOROMETHYLANILINE
Hazard Class: 6.1
UN Number: 2948
Packing Group: II
RID/ADR
Shipping Name: 3-TRIFLUOROMETHYLANILINE
Hazard Class: 6.1
UN Number: 2948
Packing group: II
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 21/22 Harmful in contact with skin and if
swallowed.
R 36/38 Irritating to eyes and skin.
Safety Phrases:
S 28A After contact with skin, wash immediately with
plenty of water.
S 36/37 Wear suitable protective clothing and
gloves.
WGK (Water Danger/Protection)
CAS# 98-16-8: 2
Canada
CAS# 98-16-8 is listed on Canada's NDSL List.
CAS# 98-16-8 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 98-16-8 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #7 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
5-Hydroxy-n omega-methyltryptamine oxalate 99%
| 15558-50-6 |
|
Coumarin 6, Laser Grade, 98% (UV-Vis)
| 38215-36-0 |
|
Iodobenzene, 98%
| 591-50-4 |
|
Oxalyl bromide, 98%
| 15219-34-8 |
|
Borane-trimethylamine complex, 98% (titr.)
| 75-22-9 |
|
1,2,4-1H-Triazole, 99.5%
| 288-88-0 |
|
Benzoic acid ammonium salt, 99% (titr.)
| 1863-63-4 |
|
2-Methyl-Cyclopropane-Methanol (Mixture of Cis and Trans), 98%
| 6077-72-1 |
|
Dowex 1x8-50 Ion-Exchange Resin
| 69772-06-1 |
|
Poly (4-Vinylpyridinium Dichromate),Cross Linked with 2% DVB;2.2mmol
| 82246-45-5 |
|
Coumarin 334, Laser Grade, 99% (UV-Vis)
| 55804-67-6 |
|
Cinnamyl alcohol, 98%
| 104-54-1 |
|
Potassium trichloro(ethylene)platinate(ii) monohydrate
| 12012-50-9 |
|
3-Tert-Butyl Adipic Acid, 99%(GC)
| 10347-88-3 |
|
Vanadium(iv) oxide, 99.9%
| 12036-21-4 |
|
3-Aminobenzotrifluoride, 99+ %
| 98-16-8 |
|
4,4-Dimethyl-2-pentanol, 99%
| 6144-93-0 |
|
Benzyl levulinate, 96%(GC)
| 6939-75-9 |
|
2,3,5,6-Tetrafluorophenol, 97+%
| 769-39-1 |
|
1-Bromo-3-chloropropane, 99%
| 109-70-6 |
|
3-Mercapto-1,2-propanediol, 90 wt% aqueous solution
| 96-27-5 |
|
Acetylenedicarboxamide (pract)
| 543-21-5 |
|
4-Heptyloxyphenol, 99%
| 13037-86-0 |
|
1-Bromo-3-Fluoro-4-Iodobenzene, 99+%
| 105931-73-5 |
|
Benzyl phenyl sulfide, 99%
| 831-91-4 |
|
1,5-Pentamethylenetetrazole, 98%
| 54-95-5 |
|
Lepidine (4-methylquinoline), 99%
| 491-35-0 |
|
2-Methyl-1-tetralone, 99%
| 1590-08-5 |
|
3-Ethoxy-2-Cyclohexen-1-One, 99%
| 5323-87-5 |
|
Hydroquinone Bis(2-Hydroxyethyl)ether, 97% (GC)
| 104-38-1 |
|
(2S,3S)-3-Methylpyrrolidine-2-carboxylic acid, 97%
| 0-01-1 |
|
Cholesteryl 2-ethylhexanoate
| 41329-01-5 |
|
Thiobenzamide, 95%
| 2227-79-4 |
|
(S)-(+)-2-Phenylpropionic acid, 99%
| 7782-24-3 |
|
Lycopodium Powder
| 8023-70-9 |
|
Isopropylcyclohexane, 97%
| 696-29-7 |
|
2-Hydrazinobenzothiazole, 99% (Titr.)
| 615-21-4 |
|
n,n-Dimethyl-p-Toluidine, 99%
| 99-97-8 |
|
3-Iodo-4-Methylbenzoic Acid, 97%
| 82998-57-0 |
|
Europium (III) Sulfate Octahydrate, 99.99%
| 10031-55-7 |
|
4,4,5,5,6,6,6-Heptafluoro-1-(2-thienyl)- 1,3-hexanedione
| 559-94-4 |
|
4-Bromoresorcinol, 99%
| 6626-15-9 |
|
1-Octen-3-ol, 98%
| 3391-86-4 |
|
5-Bromo-2-chlorobenzotrifluoride,techn. 94 %
| 445-01-2 |
|
3-Chloropropionyl Chloride, 98%
| 625-36-5 |
|
Alpha, Alpha, Alpha-Trifluoro-P-Toluic Acid, 98%
| 455-24-3 |
|
2-Bromo-2-Phenylacetophenone
| 1484-50-0 |
|
Silicon, Powder, -325 Mesh, 99+%
| 7440-21-3 |
|
Ethylene oxide, 99+%
| 75-21-8 |
|
Atropine Sulfate Monohydrate, 98.5% (Dry Substance)
| 5908-99-6 |
|
|